Category: Drug Discovery
Global Drug Discovery
-
Infectious Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV, Others), By End Use (Hospitals, Clinics, Others), By Region, and By Competition
... Competition Global Infectious Disease Therapeutics Market was valued at USD 67.04 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.00% through 2029. The Global Infectious ... Read More
-
Spectrometry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Type (Molecular Spectrometry, Mass Spectrometry (MS), Atomic Spectrometry), By Product (Instrument, Consumables, Services), By Application (Proteomics, Metabolomics, Pharmaceutical Analysis, Forensic Analysis, Others) Region and Competition
... Others) Region and Competition Global Spectrometry Market was valued at USD 12.78 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.56% through 2029. The Global ... Read More
-
Global Crohn’s Disease Therapeutics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Crohn’s Disease Therapeutics is forecast to a readjusted size of US$ 3593 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential ... Read More
-
Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029
... billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029). The COVID-19 pandemic significantly impacted the healthcare systems, affecting not only patients infected with COVID-19 but also others, resulting in disruptions ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029). The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, as ... Read More
-
Real World Evidence Solutions Market by Component (Services, Disparate Data Sets (Clinical), Application (Drug and Medical Device Development and Approvals), Mode of Deployment, Revenue Model, End Users, & Region, Business Model - Global Forecast to 2029
... 2029 The global Real-World Evidence Solutions market is projected treach USD 4.5 Billion by 2029 from USD 2.0 billion in 2024, at a CAGR of 16.5% from 2024 t2029. The growth of the market is ... Read More
-
Global Multiple Sclerosis (MS) Drugs Market Growth 2024-2030
... downstream market, the Multiple Sclerosis (MS) Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Renal Anemia Therapeutics Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Renal Anemia Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
RNA Targeting Small Molecules Therapeutics Global Market Report 2024
... Neurodegenerative Diseases; Autoimmune; Inflammatory3) By Application: Drug Discovery; Oncology Research; Disease Identification4) By End User: Hospitals; Research Laboratories; Pharmaceutical And Biotechnology CompaniesCovering: F. Hoffmann-La Roche Ltd.; Bayer AG; Sanofi S.A.; AstraZeneca plc; Eli Lilly and ... Read More
-
Small Molecule Innovator CDMO Global Market Report 2024
... Metabolic Disorders; Infectious Disease4) By Customer: Pharmaceutical; BiotechnologyCovering: Thermo Fisher Scientific Inc.; Boehringer Ingelheim International GmbH; Evonik Industries AG; Lonza Group Ltd. ; Labcorp Drug Development Small Molecule Innovator CDMO Global Market Report 2024 from ... Read More
-
RNA Targeting Small Molecule Drug Discovery Global Market Report 2024
... RNA (siRNA); Ribozymes3) By Therapeutic Area: Oncology; Neurology; Infectious Disease; Metabolic Diseases; Genetic Disorders4) By Delivery Method: Intravenous (IV); Oral; Topical5) By Application: Research Use; Therapeutic Use; Diagnostic UseCovering: F. Hoffmann-La Roche Ltd. ; Merck ... Read More
-
Mid-Size Pharmaceuticals Global Market Report 2024
... International Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co Ltd.; Arkema Inc.; Astellas Pharma Inc. Mid-Size Pharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Gout Therapeutics Global Market Report 2024
... Sanofi-Aventis; AstraZeneca plc; LG Chem Ltd.; GlaxoSmithKline Plc Gout Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. ... Read More
-
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024
... Supermarkets4) By Application: Crohn’s Disease; Gastroesophageal Reflux Disease (GERD); Ulcerative ColitisCovering: Pfizer Inc.; Johnson and Johnson; Novartis AG; Sanofi S.A.; AstraZeneca plc Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024 from The Business Research Company ... Read More
-
Global Alzheimer's Drugs Market Growth 2024-2030
... Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Alzheimer's Drugs market. Alzheimer's Drugs ... Read More
-
Global Multiomics Market, By Product & Service (Products, Services), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The global multiomics market was valued at ... Read More
-
Allergic Rhinitis Drugs Market Report 2024-2034
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Prevalence of Allergic Rhinitis Allergic rhinitis, often ... Read More
-
Genomics Market by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction), Application (Drug Discovery, Diagnostic, Research), End User (Pharmaceutical, Hospital, Academic), Offering (Instrument, Consumables, Software) - Global Forecast to 2031
... PCR, Nucleic Acid Extraction) Application (Drug Discovery, Diagnostic, Research) End User (Pharmaceutical, Hospital, Academic) Offering (Instrument, Consumable, Software)—Global Forecast to 2031 The global genomics market is projected to reach $70.52 billion by 2031, at a ... Read More
-
Global Parkinson's Disease Therapeutics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Parkinson's Disease Therapeutics is forecast to a readjusted size of US$ 3605.2 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential ... Read More
-
Antifungal Treatment Market Research Report Forecast to 2032
... immunological infections are emphatically adding to the market development. Contagious diseases incorporate both foundational and shallow contaminations, including contaminations of the skin, eye, mouth, and vagina. Antifungal items with fungicidal movement are for the most ... Read More
-
Global Migraine Drugs Market Growth 2024-2030
... Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Migraine Drugs market. Migraine Drugs ... Read More
-
Global Multiple Sclerosis Drugs Market Growth 2024-2030
... market, the Multiple Sclerosis Drugs is forecast to a readjusted size of US$ 20360 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global ... Read More
-
Multiple Sclerosis Drugs Global Market Report 2024
... Inc.; Novartis International AG; F. Hoffmann-La Roche Ltd.; Bayer HealthCare LLC; Pfizer Inc. Multiple Sclerosis Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information ... Read More
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
... recombinant proteins market size is projected to reach USD 3.2 billion by 2028 from USD 2.2 billion in 2023, at a CAGR of 7.2% during the forecast period. Factors such as rising demand for biologics ... Read More
-
Epilepsy Therapeutics Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Medical Advances Driving Epilepsy Treatment Market Growth In the ever-evolving ... Read More
Research Assistance
